Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This prospective, single-centre, parallel-group randomised controlled trial evaluates the optimal sequencing of mammography views in women with a history of breast cancer undergoing surveillance mammography. Women treated with breast-conserving surgery within the previous five years will be randomised 1:1:1:1 to one of four mammography view sequencing groups.
The primary objective is to compare patient-reported pain and satisfaction across sequencing groups. Secondary objectives include comparison of image quality (PGMI scoring), compression force, and breast thickness.
A total of 400 participants will be enrolled at Beaumont Hospital Breast Care Centre over 2.5 years.
Women with a history of breast cancer routinely undergo annual surveillance mammography following breast-conserving surgery and radiotherapy. Standard mammography includes mediolateral oblique (MLO) and craniocaudal (CC) views of each breast. However, there is limited evidence regarding whether the order in which these views are obtained affects patient experience or image quality.
This study randomises 400 women (1:1:1:1) to four different view sequencing protocols:
Pain is assessed using a visual analogue scale (VAS) before and after mammography. Patient satisfaction is measured using a post-procedure questionnaire. Image quality will be assessed retrospectively using PGMI scoring by two radiologists. Compression force and breast thickness will also be recorded.
The study uses an intention-to-treat analysis framework.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Untreated MLO First | Experimental | Participants undergo surveillance mammography in the following sequence: Untreated mediolateral oblique (MLO), Treated MLO, Untreated craniocaudal (CC), Treated CC. |
|
| Untreated CC First | Experimental | Participants undergo surveillance mammography in the following sequence: Untreated CC, Treated CC, Untreated MLO, Treated MLO. |
|
| Treated MLO First | Experimental | Participants undergo surveillance mammography in the following sequence: Treated MLO, Untreated MLO, Treated CC, Untreated CC. |
|
| Treated CC First | Experimental | Participants undergo surveillance mammography in the following sequence: Treated CC, Untreated CC, Treated MLO, Untreated MLO. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Mammography View Sequencing | Procedure | Standard surveillance mammography consisting of MLO and CC views of both treated and untreated breasts. Participants are randomised to one of four predefined sequences determining the order in which views are obtained. No additional imaging beyond standard of care is performed. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Patient-Reported Pain Score During Mammography | Pain will be measured using a 10-point Visual Analogue Scale (VAS). Pain scores will be recorded immediately prior to mammography and immediately following completion of mammography. The primary analysis will compare post-procedure pain scores across the four randomised sequencing groups. | Immediately before and immediately after mammography (same study visit) |
| Patient Satisfaction Following Mammography | Patient satisfaction will be assessed immediately after mammography using a structured electronic questionnaire administered via MS Forms. Responses will be compared across the four sequencing groups. | Immediately after mammography (same study visit) |
| Measure | Description | Time Frame |
|---|---|---|
| Image Quality (PGMI Score) | Image quality will be assessed retrospectively using the PGMI (Perfect, Good, Moderate, Inadequate) scoring system by two radiologists. PGMI scores will be compared across sequencing groups. | Following image acquisition (retrospective review after mammography during normal reporting timeframe institutionally) |
Not provided
Inclusion Criteria:
Female patients aged 18 years or older History of breast cancer treated with breast-conserving surgery (wide local excision) Undergoing first annual surveillance mammogram following completion of surgery and radiotherapy Within five years of breast cancer treatment May have history of whole-breast or partial-breast radiotherapy May have history of axillary surgery Able and willing to provide informed consent
Exclusion Criteria:
Male patients Patients younger than 18 years History of mastectomy History of bilateral wide local excision Lack of capacity to provide informed consent More than five years since completion of breast cancer treatment
Eligibility is based on biological sex (female), not gender identity criteria beyond biological sex.
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Prof Nuala Healy | Contact | +35318093000 | nualahealy@rcsi.ie |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Beaumont RCSI Cancer Centre | Recruiting | Beaumont | Dublin | D09V2N0 | Ireland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Participants will be randomised in a 1:1:1:1 ratio to one of four mammography view sequencing groups. Each group undergoes standard surveillance mammography consisting of mediolateral oblique (MLO) and craniocaudal (CC) views of both treated and untreated breasts, performed in a different predefined sequence. The intervention involves the order in which views are obtained. All participants receive the same imaging views; only the sequence differs. There is no crossover between groups. Analysis will be conducted on an intention-to-treat basis.
Not provided
Not provided
Not provided
Not provided
|
| Compression Force During Mammography |
Compression force applied during mammography will be recorded in Newtons from the mammography unit and compared across sequencing groups. |
| During mammography (same study visit) |
| Breast Thickness During Mammography | Compressed breast thickness will be recorded in millimetres from the mammography system and compared across sequencing groups. | During mammography (same study visit) |
| Mean Glandular Radiation Dose | Mean glandular dose (MGD) will be recorded from the mammography unit for each participant and compared across sequencing groups. | During mammography (same study visit) |
| Duration of Mammography Procedure | Total time taken to complete mammography will be recorded in minutes and compared across sequencing groups. | During mammography (same study visit) |
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
Not provided
Not provided